ORMP
ORAMED PHARMACEUTICALS INC.
Key Financials
Gross Profit
$13000
N/A
Revenue
$2.0M
↑ 49.3%
EPS (Diluted)
$1.50
↑ 412.5%
Operating Income
$-15088000
↓ 18.1%
Total Liabilities
$502688.00
N/A
Net Income
$64.0M
↑ 435.3%
Total Assets
$230.9M
↑ 48.7%
Long-term Debt
$25000.00
↓ 99.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/10/2026 | View on SEC |
| ARS | 8/3/2026 | View on SEC |
| DEFA14A | 8/3/2026 | View on SEC |
| DEF 14A | 8/3/2026 | View on SEC |
| SCHEDULE 13D/A | 7/22/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 144 | 7/1/2026 | View on SEC |
| 144 | 7/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ORMP |
| Company Name | ORAMED PHARMACEUTICALS INC. |
| CIK | 1176309 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 646-844-1164 |